Jing Cheng
Impact in
-
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 14
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Ting Hu (5 shared papers)Yuxiu Xie (4 shared papers)Qiong Wang (4 shared papers)Renwang Chen (3 shared papers)Gang Yi Wu (3 shared papers)Qian Ding (2 shared papers)Jing Chai (2 shared papers)Jue Wang (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)International Journal of Radiation Biology (2 papers)Frontiers in Pharmacology (2 papers)The Breast (2 papers)Nature Medicine (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jing Cheng
43 papers receiving 704 citations
Jing Cheng's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 119
- Oncology 199
- Pulmonary and Respiratory Medicine 207
- Radiology, Nuclear Medicine and Imaging 63
- Genetics 29
Countries citing papers authored by Jing Cheng
This map shows the geographic impact of Jing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Cheng more than expected).
Fields of papers citing papers by Jing Cheng
This network shows the impact of papers produced by Jing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Cheng. The network helps show where Jing Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 122 | |
| 2 | Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2024 | 91 |
| 3 | 2023 | 61 | |
| 4 | 2014 | 43 | |
| 5 | 2021 | 35 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 26 | |
| 8 | 2014 | 25 | |
| 9 | 2017 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 17 | |
| 12 | 2009 | 17 | |
| 13 | 2015 | 15 | |
| 14 | 2016 | 15 | |
| 15 | 2013 | 15 | |
| 16 | 2024 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2018 | 10 |
About Jing Cheng
Jing Cheng is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 43 papers that have together received 715 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (4 papers), Autophagy in Disease and Therapy (3 papers), DNA Repair Mechanisms (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Effects of Radiation Exposure (3 papers), Lung Cancer Treatments and Mutations (3 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (119 citations), Oncology (199 citations), Pulmonary and Respiratory Medicine (207 citations), Radiology, Nuclear Medicine and Imaging (63 citations) and Genetics (29 citations). Jing Cheng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Ting Hu, Yuxiu Xie, Qiong Wang, Renwang Chen, Gang Yi Wu, Qian Ding, Jing Chai, Jue Wang, Debin Wang and Gang Peng. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Radiation Biology, Frontiers in Pharmacology, The Breast and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.